Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphopenia × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Lung Neoplasms 5 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Hot Flashes 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Surgical Wound 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Lymphopenia 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Lower Urinary Tract Symptoms 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Heart Failure 1 Glioma 1 Gastrointestinal Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 Ectropion 1 Dupuytren Contracture 1

Interventions

Interleukin-7 2 Thymalfasin 1 Sodium Chloride 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04426201 2024-04-11

ILIAD-7-US-O

Revimmune

Phase 2 Terminated

COVID-19, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡